About
Pulnovo Medical
Pulnovo Medical Limited, is a globally recognized device
pioneer in the
treatment for pulmonary hypertension and heart failure. Established in 2013 and rooted in
innovation, Pulnovo Medical is committed to leveraging our deep expertise in the science of
breakthrough technologie with the goal to market our innovative therapeutic solutions and
benefit patients around the world.
Patients it may cover
70150900
A Globally Recognized Device Pioneer
Take the innovative technologies as the engine, explore the huge unmet clinical market
ofpulmonary hypertension and heart failure.
Forward-looking Business Strategy
Achieving Global Layout by Relying on Differentiated Resources in Different Regions
USA
Clinical Landscape
Regulatory Pathway
Europe
Clinical Landscape
Regulatory Pathway
Asia
R & D resources
Production Management
Clinical Landscape
Regulatory Pathway
Middle East
Regulatory Pathway
Key Milestones & Endorsements
2024
The global clinical study of PADN technology in
treating.Pulmonary
Hypertension Associated with Left Heart Diseasewas successfully conducted in
Portugal, Singapore, andMalaysia, with the first enrollment.
2024.03
The world's first post-market PADN procedure was
successfullyperformed at the Xiamen Cardiovascular Hospital Xiamen University.
2024.03
PADN obtained the U.S. Medicare coverage code by Center for
Medicare&Medicaid Services(CMS) approval.
2024.03
PADN obtained the U.S. Medicare coverage code by Center for
Medicare&Medicaid Services(CMS) approval.
Cookie Policy
·
Legal Statement
·
Privacy Policy
Copyright © 2025 PULNOVO MEDICAL
